Emergent BioSolutions' executives were grilled in a Capitol Hill hearing Wednesday.
Lawmakers wanted answers on what went wrong at the Baltimore facility when products that would have been used for millions of doses of the Johnson & Johnson COVID-19 vaccine became contaminated.